Serina Therapeutics (SER) Invested Capital (2017 - 2025)
Serina Therapeutics (SER) posted Invested Capital of $2.9 million for Q3 2025, up 288700.0% sequentially from $1000.0 in Q4 2024, and up 288700.0% YoY from N/an in Q3 2024.
Serina Therapeutics (SER) Invested Capital (2017 - 2025) Analysis & Trends
Serina Therapeutics has reported Invested Capital for 9 years, with the latest figure at $2.9 million in Q3 2025.
- Quarterly Invested Capital rose 288700.0% year-over-year to $2.9 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 million (down 85.7% YoY) and the FY2024 annual result came in at $1000.0, down 97.3% from the prior year.
- Invested Capital climbed to $2.9 million in Q3 2025 per SER's latest filing, from $1000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $22.9 million in Q2 2023 and troughed at $1000.0 in Q3 2024.
- A 5-year average of $6.3 million and a median of $5.6 million in 2021 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Invested Capital sank 99.93% in 2024, then jumped 288700.0% in 2025.
- Over 5 years, Invested Capital stood at $7.1 million in 2021, then rose by 7.09% to $7.6 million in 2022, then sank by 99.52% to $37000.0 in 2023, then sank by 97.3% to $1000.0 in 2024, then surged by 288700.0% to $2.9 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $2.9 million, $1000.0, and $1000.0 for Q3 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.89 Mn |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 10.45 Mn |
| Mar 31, 2024 | 9.75 Mn |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 22.94 Mn |
| Mar 31, 2023 | 20.04 Mn |
| Dec 31, 2022 | 7.65 Mn |
| Sep 30, 2022 | 59,000.00 |
| Jun 30, 2022 | 6.97 Mn |
| Mar 31, 2022 | 6.66 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 3.56 Mn |
| Mar 31, 2021 | 2.02 Mn |
| Dec 31, 2020 | 1.96 Mn |
| Sep 30, 2020 | 435,000.00 |
| Jun 30, 2020 | 1.82 Mn |